Latest Insider Transactions at Day One Biopharmaceuticals, Inc. (DAWN)
This section provides a real-time view of insider transactions for Day One Biopharmaceuticals, Inc. (DAWN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Day One Biopharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Day One Biopharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
Canaan Xi L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,476,776
+21.15%
|
-
|
|
Jun 01
2021
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+50.0%
|
$8,000,000
$16.0 P/Share
|
|
Jun 01
2021
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
8,502,776
+50.0%
|
-
|
|
Jun 01
2021
|
Papanek Julie Grant Director |
BUY
Open market or private purchase
|
Indirect |
13,000
+0.12%
|
$208,000
$16.0 P/Share
|
|
Jun 01
2021
|
Papanek Julie Grant Director |
BUY
Conversion of derivative security
|
Indirect |
7,476,776
+21.15%
|
-
|
|
Jun 01
2021
|
Daniel J. Becker Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$80,000
$16.0 P/Share
|
|
Jun 01
2021
|
John A. Josey |
BUY
Open market or private purchase
|
Direct |
7,000
+8.83%
|
$112,000
$16.0 P/Share
|